PRNewsWire - Health

FDA Approves New, Low-Dose Chlorthalidone for the Treatment of Hypertension in Adults: HemiClor™ (12.5 mg chlorthalidone)
Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
Trusted by healthcare leaders: Medical Solutions earns Top 10 MSP spot for fourth year
RIFM Principal Scientist Dr. Isabelle Lee to Deliver Keynote at the 8th World Candle Congress